Fungal Infection in HIV-Infected Patients-Is It Still a Challenge?

Area of Science:

• Medical Mycology
• Infectious Diseases
• Immunocompromised Host Infections

Background:

• Fungal infections are common opportunistic infections in individuals with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS).
• Specific fungi like Pneumocystis jirovecii, Cryptococcus neoformans, Histoplasma capsulatum, and Candida spp. disproportionately affect HIV-infected individuals.
• While antiretroviral therapy has reduced invasive fungal infections, untreated or non-adherent patients remain at high risk.

Purpose of the Study:

• To provide an overview of prevalent fungal infections in HIV-positive patients.
• To discuss the evolving epidemiology and etiology of these infections.
• To highlight current therapeutic challenges, including rising antifungal resistance.

Main Methods:

• Literature review of common fungal infections in HIV/AIDS patients.
• Analysis of epidemiological trends and etiological shifts.
• Discussion of current treatment strategies and challenges.

Main Results:

• Antiretroviral therapy has decreased invasive fungal infections in HIV patients.
• Untreated or poorly adherent HIV patients face severe complications and mortality from fungal infections.
• Increasing numbers of immunocompromised patients and rising antifungal resistance pose growing public health concerns.

Conclusions:

• Fungal infections continue to be a critical concern in HIV/AIDS management.
• The landscape of fungal infections in HIV is changing due to treatment adherence and broader immunocompromised populations.
• Addressing antifungal resistance and optimizing treatment strategies are essential for improving patient outcomes.